首页> 外文会议>Cell culture engineering XV >CHO-K1 HOST CELL ENGINEERING STRATEGY ENABLING THE ESTABLISHMENT OF STRAINS PRODUCING HIGHER YIELDS OF RECYCLING ANTIBODIES
【24h】

CHO-K1 HOST CELL ENGINEERING STRATEGY ENABLING THE ESTABLISHMENT OF STRAINS PRODUCING HIGHER YIELDS OF RECYCLING ANTIBODIES

机译:CHO-K1宿主细胞工程学策略可建立可产生更高回收率抗体的菌株

获取原文
获取原文并翻译 | 示例

摘要

As described elsewhere (Biotechnol Bioeng 2010, 2013), our DXB11 (dhfr~-) host cell engineering strategy achieved high cell viability for a prolonged period (more than 1 month) and enhanced mAb productivity (>100 pg/cell/day) by nutritional control. Introduction of taurine transporter (TAUT) into DXB11 parent cells increased glutamine uptake and accelerated glutathione metabolism. By forcing the overexpression of TAUT, we were able to control DXB11 host cell functions and thereby increase the monoclonal antibody (mAb) titer up to 8.1 g/L/31 days under conventional 1-L bioreactor fed-batch conditions. Furthermore, the mAb produced by the DXB11/TAUT cells was comparable in quality to the mAb produced by the parent cells. In this study, we used CHO-K1 host cells and a chemically defined medium (CDM) for the development of cell lines producing recycling antibodies (rcAb). CDM adaptation and TAUT overexpression improved CHO-K1 cell performance. Rapid-growth CHO-K1/TAUT cells were developed, and these enabled the establishment of strains that produced higher yields of rcAb than did CHO-K1 parent cell (p < 0.05). Viable cell density of these CHO-K1/TAUT/rcAb strains increased not only under shaker passage culture conditions (p <0.01) but also under shaker fed-batch culture conditions (p < 0.01). These results suggest that our TAUT overexpression strategy also has a unique potential for the improvement of CHO-K1 host cells as well as DXB11 host cells.
机译:如其他地方所述(Biotechnol Bioeng 2010,2013),我们的DXB11(dhfr〜-)宿主细胞工程策略可延长细胞存活率(超过1个月),并提高mAb生产率(> 100 pg /细胞/天),营养控制。牛磺酸转运蛋白(TAUT)引入DXB11亲本细胞可增加谷氨酰胺摄取并加速谷胱甘肽代谢。通过强迫TAUT的过表达,我们能够控制DXB11宿主细胞功能,从而在传统的1L生物反应器分批补料条件下将单克隆抗体(mAb)滴度提高至8.1 g / L / 31天。此外,DXB11 / TAUT细胞产生的mAb在质量上与亲本细胞产生的mAb相当。在这项研究中,我们使用CHO-K1宿主细胞和化学成分确定的培养基(CDM)来开发产生循环抗体(rcAb)的细胞系。 CDM适应和TAUT过表达改善了CHO-K1细胞的性能。快速生长的CHO-K1 / TAUT细胞得到了发展,这些细胞能够建立比CHO-K1亲本细胞产生更高rcAb产量的菌株(p <0.05)。这些CHO-K1 / TAUT / rcAb菌株的活细胞密度不仅在摇床传代培养条件下(p <0.01)增加,而且在摇床分批补料培养条件下(p <0.01)也增加。这些结果表明,我们的TAUT过表达策略还具有改善CHO-K1宿主细胞以及DXB11宿主细胞的独特潜力。

著录项

  • 来源
    《Cell culture engineering XV》|2016年|161-162|共2页
  • 会议地点 Palm Springs(US)
  • 作者单位

    Chugai Pharmaceutical Co., LTD. API Process Development Dept. (Bio Technology), 5-5-1, Ukima, Kitaku, Tokyo, 115-8543 Japan;

    Chugai Pharmaceutical Co., LTD. Masaki Yamaguchi, Chugai Pharmaceutical Co., LTD.;

  • 会议组织
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    CHO-K1; CDM; TAUT; overexpression; rcAb;

    机译:CHO-K1; CDM; TAUT;过度表达抗体;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号